✦ LIBER ✦

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

✍ Scribed by Clavarezza, Matteo; Turazza, Monica; Aitini, Enrico; Saracchini, Silvana; Garrone, Ornella; Durando, Antonio; De Placido, Sabino; Bisagni, Giancarlo; Levaggi, Alessia; Bighin, Claudia; Restuccia, Eleonora; Scalamogna, Roberto; Galli, Anna; Del Mastro, Lucia

Book ID: 123040449
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 287 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2013.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed in Patients with Locally Adva

Pemetrexed in Patients with Locally Advanced or Metastatic Breast Cancer Who Had Received Previous Anthracycline and Taxane Treatment: Phase II Study

✍ Antonio Llombart-Cussac; Maria Theodoulou; Kendrith Rowland; Romnee S. Clark; Ta 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

Phase II Study of Pemetrexed in Patients

Phase II Study of Pemetrexed in Patients Pretreated with an Anthracycline, a Taxane, and Capecitabine for Advanced Breast Cancer

✍ Joyce A. O'Shaughnessy; Romnee S. Clark; Joanne L. Blum; Robert G. Mennel; David 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 518 KB

Neoadjuvant capecitabine chemoradiation

Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial

✍ M.D.F. Gaui; Amorim; R. Arcuri; G. Pereira; D. Moreira; C. Djahjah; N. Spector 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II Study of Neoadjuvant Weekly nab

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer

✍ Denise A. Yardley; Eric Raefsky; Raul Castillo; Anup Lahiry; Richard LoCicero; D 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 370 KB

Phase II study of docetaxel, capecitabin

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

✍ Yen-Shen Lu; Dar-Ren Chen; Ling-Min Tseng; Dah-Cherng Yeh; Shou-Tung Chen; Chia- 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Phase I/II study of neoadjuvant bevacizu

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

✍ Blaszkowsky, L. S.; Ryan, D. P.; Szymonifka, J.; Borger, D. R.; Zhu, A. X.; Clar 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 142 KB